Pfizer eyes po­ten­tial sale of con­sumer health arm

The Daily Telegraph - Business - - Business -

Pfizer is con­sid­er­ing the sale or spin-off of its con­sumer health­care busi­ness in a deal that could raise up to $14bn (£10.6bn) of cash for the phar­ma­ceu­ti­cals group. The firm said that it was con­sid­er­ing op­tions for the di­vi­sion, which makes ChapStick lip balm and mul­ti­vi­ta­mins, one of which was re­tain­ing it.

Newspapers in English

Newspapers from UK

© PressReader. All rights reserved.